Ex Parte Sullivan - Page 12




               Appeal No. 2004-0242                                                                        Page 12                   
               Application No. 09/873,594                                                                                            


               the rejection is predicated upon a combination of prior art disclosures.  See In re Merck                             
               & Co. Inc., 800 F.2d 1091, 1097, 231 USPQ 375, 380 (Fed. Cir. 1986).  In our view, the                                
               combined teachings of Nesbitt and Wu are clearly suggestive of the claimed subject                                    
               matter as set forth above.  Lastly, we incorporate the examiner's response to the                                     
               appellant's argument (answer, pp. 4-7) as our own.                                                                    


                       For the reasons set forth above, the decision of the examiner to reject                                       
               independent claims 1, 7 and 13, and claims 4 to 6, 10 to 12 and 16 to 18 dependent                                    
               thereon, under 35 U.S.C. § 103 is affirmed.                                                                           


                                                         CONCLUSION                                                                  
                       To summarize, the decision of the examiner to reject claims 1, 4 to 7, 10 to 13                               
               and 16 to 18 under 35 U.S.C. § 103 is affirmed.                                                                       




















Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  Next 

Last modified: November 3, 2007